Given Zydus Lifesciences and Dr Reddy’s Laboratories have high US sales exposure with ~45% and 43% sales contribution, ...
The Hatch Waxman Act and the Biological Price Competition and Innovation Act have incentivized efforts to improperly prolong ...
The Hatch-Waxman Act seeks to strike a balance in the pharmaceutical industry by incentivizing drugs makers to develop ...
The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug ...
Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...
Tariffs on Indian generics could raise US drug prices, disrupt supply chains, and strain insurance systems. Indian firms, ...
Consumers who purchased certain generic prescription drugs between May 2009 and December 2019 are eligible for compensation.
Nevada Attorney General Aaron Ford is urging residents to check their eligibility for compensation if they purchased certain ...
Arizona AG urges eligible consumers to claim compensation from a $39.1 million Apotex settlement over inflated generic drug ...
Generic drug makers settlement ï’µNJ among 26 states involved ï’µResolves conspiracy to inflate prices TRENTON - New Jersey ...
Nevada Attorney General Aaron Ford is urging consumers to check their eligibility for compensation as the state joins a $39.1 ...
Indiana is joining nearly every U.S. state and territory in moving forward with a settlement in a nationwide price-fixing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback